News List

News List

VISEN Pharmaceutical's TransCon C-type natriuretic peptide Phase II clinical trial application approved in China

January 7, VISEN Pharmaceuticals announced that it had submitted TransCon CNP (TransCon C-type natri

READ MORE 2021-02-08
Progress in the development of new and efficient diabetes treatment drugs

Recently, Wang Junfeng's research team from Hefei Institute of Material Science, Chinese Academy

READ MORE 2021-01-19
FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA
FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S.

READ MORE 2020-12-22
Merck's new HIV drug Pedro (Doravirin) was approved in China
Merck's new HIV drug Pedro (Doravirin) was approved in China

Merck announced recentlythat its new HIV drug Pedro (doravirin tablets) has been officially approved

READ MORE 2020-12-08
ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shion

READ MORE 2020-10-18
European Commission Grants Marketing Authorization for Jyseleca® ▼ (Filgotinib) for the Treatment of Adults With Moderate to Severe Active Rheumatoid Arthritis
European Commission Grants Marketing Authorization for Jyseleca® ▼ (Filgotinib) for the Treatment of Adults With Moderate to Severe Active Rheumatoid Arthritis

Gilead Sciences and Galapagos NV today announced that the European Commission (EC) has granted marke

READ MORE 2020-09-27
Gastrointestinal stromal tumor (GIST) targeted new drugs! Avapritinib will be approved in the EU in September
Gastrointestinal stromal tumor (GIST) targeted new drugs! Avapritinib will be approved in the EU in September

Blueprint Medicines announced that the European Medicines Agency (EMA) Committee for Medicinal Produ

READ MORE 2020-07-29